Junyan Xu

943 total citations
35 papers, 679 citations indexed

About

Junyan Xu is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Junyan Xu has authored 35 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Surgery. Recurrent topics in Junyan Xu's work include Medical Imaging Techniques and Applications (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). Junyan Xu is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Radiomics and Machine Learning in Medical Imaging (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). Junyan Xu collaborates with scholars based in China, United States and Australia. Junyan Xu's co-authors include Yingjian Zhang, Sanjun Cai, Jingyi Cheng, Lingling Pan, Fangqi Liu, Ji Zhu, Yifei Sun, Yongping Zhang, Zhimin Shao and Qingguo Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Junyan Xu

27 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junyan Xu China 15 272 204 173 163 161 35 679
Li‐Yu Lee Taiwan 14 208 0.8× 138 0.7× 263 1.5× 136 0.8× 158 1.0× 15 780
Markus W. Groß Germany 15 149 0.5× 197 1.0× 163 0.9× 218 1.3× 171 1.1× 24 866
Ping Han China 17 168 0.6× 112 0.5× 133 0.8× 166 1.0× 134 0.8× 67 791
Naohito Yamamoto Japan 16 405 1.5× 106 0.5× 189 1.1× 114 0.7× 272 1.7× 75 892
A. Magener Germany 13 294 1.1× 365 1.8× 145 0.8× 131 0.8× 235 1.5× 24 920
Stephan Tschirdewahn Germany 16 197 0.7× 96 0.5× 174 1.0× 269 1.7× 159 1.0× 57 677
Tomohiro Fujii Japan 19 261 1.0× 189 0.9× 155 0.9× 310 1.9× 65 0.4× 47 887
Julie Steinestel Germany 19 304 1.1× 81 0.4× 229 1.3× 473 2.9× 306 1.9× 42 1.0k
Guenther Gruber Switzerland 10 161 0.6× 112 0.5× 140 0.8× 161 1.0× 164 1.0× 17 634
Takatsugu Mizumachi Japan 20 346 1.3× 107 0.5× 422 2.4× 221 1.4× 206 1.3× 67 1.2k

Countries citing papers authored by Junyan Xu

Since Specialization
Citations

This map shows the geographic impact of Junyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junyan Xu more than expected).

Fields of papers citing papers by Junyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junyan Xu. The network helps show where Junyan Xu may publish in the future.

Co-authorship network of co-authors of Junyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junyan Xu. A scholar is included among the top collaborators of Junyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junyan Xu. Junyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Junyan, et al.. (2025). Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. Cell Death Discovery. 11(1). 391–391.
3.
4.
Liu, Fei, Panli Li, Junyan Xu, et al.. (2024). Radiation exposure and protection advice after [177Lu]Lu-DOTA-TATE therapy in China. EJNMMI Research. 14(1). 119–119.
5.
Bian, Linjie, Junyan Xu, Panli Li, Liyan Bai, & Shaoli Song. (2024). Comparison of 68Ga-DOTANOC and 18F-FDOPA PET/CT for Detection of Recurrent or Metastatic Paragangliomas. Radiology Imaging Cancer. 7(1). e240059–e240059. 1 indexed citations
6.
Xin, Bowen, Ziyi Yang, Junyan Xu, et al.. (2022). Radiomic analysis for predicting prognosis of colorectal cancer from preoperative 18F-FDG PET/CT. Journal of Translational Medicine. 20(1). 66–66. 37 indexed citations
7.
8.
Yang, Ziyi, Shuai Liu, Yuyun Sun, et al.. (2021). 18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer. Neoplasma. 68(4). 875–881. 2 indexed citations
9.
Li, Jiaru, Ziyi Yang, Bowen Xin, et al.. (2021). Quantitative Prediction of Microsatellite Instability in Colorectal Cancer With Preoperative PET/CT-Based Radiomics. Frontiers in Oncology. 11. 702055–702055. 21 indexed citations
10.
Li, Yi, Junyan Xu, Xiaoping Xu, Jiangang Zhang, & Yingjian Zhang. (2019). Long-acting octreotide treatment has no impact on tumor uptake of 99mTc-HYNIC-TOC in patients with neuroendocrine tumors. Nuclear Medicine Communications. 40(10). 1005–1010. 4 indexed citations
11.
Liu, Shuai, Zheng Feng, Hao Wen, et al.. (2018). Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer. Nuclear Medicine Communications. 39(10). 928–935. 4 indexed citations
12.
Liu, Shuai, Zheng Feng, Hao Wen, et al.. (2018). Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients. Nuclear Medicine Communications. 39(4). 319–324. 1 indexed citations
13.
Li, Qingguo, Yaqi Li, Junyan Xu, et al.. (2017). Aldolase B Overexpression is Associated with Poor Prognosis and Promotes Tumor Progression by Epithelial-Mesenchymal Transition in Colorectal Adenocarcinoma. Cellular Physiology and Biochemistry. 42(1). 397–406. 54 indexed citations
14.
Zhu, Ji, Fangqi Liu, Peng Lian, et al.. (2014). Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study. Radiation Oncology. 9(1). 70–70. 51 indexed citations
15.
Chen, Zhi, Celia M.T. Greenwood, William B. Isaacs, et al.. (2013). The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial. Carcinogenesis. 34(6). 1260–1264. 43 indexed citations
16.
Cheng, Jingyi, Lei Li, Junyan Xu, et al.. (2013). 18F-Fluoromisonidazole PET/CT: A Potential Tool for Predicting Primary Endocrine Therapy Resistance in Breast Cancer. Journal of Nuclear Medicine. 54(3). 333–340. 80 indexed citations
17.
Liu, Lei, Yi Qin, C. Liu, et al.. (2013). Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Oncogene. 33(21). 2728–2736. 60 indexed citations
18.
19.
Xu, Junyan, Jurga Sauvageot, Charles M. Ewing, et al.. (2006). GermlineATBF1 mutations and prostate cancer risk. The Prostate. 66(10). 1082–1085. 18 indexed citations
20.
Lindmark, Fredrik, Shun Zheng, Fredrik Wiklund, et al.. (2004). H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer. JNCI Journal of the National Cancer Institute. 96(16). 1248–1254. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li‐Yu Lee Breakdown of academic impact, for papers by Markus W. Groß Breakdown of academic impact, for papers by Ping Han Breakdown of academic impact, for papers by Naohito Yamamoto Breakdown of academic impact, for papers by A. Magener Breakdown of academic impact, for papers by Stephan Tschirdewahn Breakdown of academic impact, for papers by Tomohiro Fujii Breakdown of academic impact, for papers by Julie Steinestel Breakdown of academic impact, for papers by Guenther Gruber Breakdown of academic impact, for papers by Takatsugu Mizumachi
Rankless by CCL
2026